As Parkinson’s disease progresses changes in memory, concentration, and mental functions become increasingly problematic. This cognitive impairment is common and symptoms become more apparent with time. As of now, there are no treatments to help.

Recently, researchers have explored whether sensitizing the dopamine receptors can help make cognitive functions better for those with Parkinson’s disease dementia. This research is being conducted due to the finding that those with Parkinson’s disease suffer from dopamine insufficiency.

The Northwest Clinical Research Center has the opportunity to evaluate this question with a novel medication. However, answering these questions cannot be done without research volunteers.

Study Medication

All patients enrolled in the study will continue to take their medications for Parkinson’s disease as well as medications to manage other health conditions. The study medication is given in addition to these treatments.

Clinical Trial Participation
Northwest Clinical Research Center is conducting a clinical research study evaluating a medication for improving cognitive function in patients diagnosed with Parkinson’s disease dementia between the ages of 40 and 80.

Medical Evaluation
Study Medication
Study Related Medical Care
Complimentary Transportation or Travel Stipend
Compensation up to $1000

For more information about participating in this clinical trial call us at (425) 453-0404 or submit your information on the top of the page.